Generate Investment Management Ltd purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 2nd quarter, HoldingsChannel.com reports. Founders Capital Management LLC raised its position in shares of Regeneron Pharmaceuticals by 7.0% in the second quarter. Get Regeneron Pharmaceuticals alerts:Regeneron Pharmaceuticals Stock Up 1.5%NASDAQ REGN opened at $563.90 on Monday. Regeneron Pharmaceuticals Announces DividendRegeneron Pharmaceuticals ( NASDAQ:REGN Get Free Report ) last announced its quarterly earnings data on Friday, August 1st. Receive News & Ratings for Regeneron Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regeneron Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.